Information Provided By: 
Fly News Breaks for January 4, 2017
A, BRKR
Jan 4, 2017 | 05:47 EDT
Barclays analyst Jack Meehan downgraded Bruker (BRKR) to Equal Weight citing a more cautious outlook on the company's European academic exposure. He lowered his price target for the shares to $22 from $30. Meehan this morning lowered his Life Science Tools & Diagnostics sector view to Neutral from Positive as he sees a more balanced set-up in the near-term. The analyst coupled the downgrade of Bruker with an upgrade of Agilent (A).
News For BRKR;A From the Last 2 Days
There are no results for your query BRKR;A
